The Risk of Upper Urinary Tract Involvement in Patients With Ketamine-Associated Uropathy
Chi-Hang Yee, Jeremy Yuen-Chun Teoh, Pui-Tak Lai, Vivian Yee-Fong Leung, Winnie Chiu-Wing Chu, Wai-man Lee, Yuk-Him Tam, Chi-Fai Ng
Int Neurourol J. 2017;21(2):128-132.   Published online 2017 Jun 21
DOI: https://doi.org/10.5213/inj.1732704.352
Citations to this article as recorded by
  Crossref logo
Toxicity and postwithdrawal effects of ketamine on the reproductive function of male albino rats: Hormonal, histological, and immunohistochemical study
MG Paulis, EM Hafez, NF El-Tahawy
Human & Experimental Toxicology.2020; 39(8): 1054.     CrossRef
What urologists need to know about ketamineā€induced uropathy: A systematic review
Daniele Castellani, Giacomo M. Pirola, Marilena Gubbiotti, Emanuele Rubilotta, Kalyan Gudaru, Andrea Gregori, Marco Dellabella
Neurourology and Urodynamics.2020; 39(4): 1049.     CrossRef
Risk of Renal Function Decline in Patients with Ketamine-Associated Uropathy
Shih-Hsiang Ou, Ling-Ying Wu, Hsin-Yu Chen, Chien-Wei Huang, Chih-Yang Hsu, Chien-Liang Chen, Kang-Ju Chou, Hua-Chang Fang, Po-Tsang Lee
International Journal of Environmental Research and Public Health.2020; 17(19): 7260.     CrossRef
Epidemiologic characteristics and risk factors in patients with ketamine-associated lower urinary tract symptoms accompanied by urinary tract infection
Weihua Liu, Weiwei Wu, Yongbao Wei, Jinfeng Wu, Tao Li, Qingguo Zhu, Liefu Ye, Fuyuan Hong, Yunliang Gao, Jinrui Yang
Medicine.2019; 98(23): e15943.     CrossRef